STAT3 and neoplasm: We also found that B-ISG15 was enriched in the IL2 STAT5 signaling and IL6 JAK STAT3 signaling gene sets, and IL-6/JAK/STAT3 signaling drives tumor cell proliferation, survival, invasion, and metastasis while inhibiting the antitumor immune response (Fig. 3C).